[go: up one dir, main page]

AR025602A1 - Composiciones farmaceuticas y/o cosmeticas - Google Patents

Composiciones farmaceuticas y/o cosmeticas

Info

Publication number
AR025602A1
AR025602A1 ARP000104710A ARP000104710A AR025602A1 AR 025602 A1 AR025602 A1 AR 025602A1 AR P000104710 A ARP000104710 A AR P000104710A AR P000104710 A ARP000104710 A AR P000104710A AR 025602 A1 AR025602 A1 AR 025602A1
Authority
AR
Argentina
Prior art keywords
derivatives
pantothenic acid
pharmaceutical
cosmetic compositions
glycine
Prior art date
Application number
ARP000104710A
Other languages
English (en)
Original Assignee
Roche Consumer Health Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Consumer Health Ag filed Critical Roche Consumer Health Ag
Publication of AR025602A1 publication Critical patent/AR025602A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

Empleo del ácido pantoténico y/o sus derivados para el tratamiento de trastornos dermatologicos que implica el proceso de desgranulacion de los mastocitos,tales como la dermatitis atopica, psoriasis, eczema de contacto, alergias de piel, inflamacionde la piel debida a las picaduras de los insectos, alergias dela piel, prurito senil. Composiciones farmacéuticas y/o cosméticas que comprenden el ácido pantoténico y/o sus derivados, glicina y/o aditivosfarmacéuticamente y cosméticamenteaceptables. El efecto de inhibicion sobre el proceso de desgranulacion de los mastocitos se incrementa fuertemente si elácido pantoténico y/o sus derivados se combinan con la glicina. Se observa por lo tanto, un efecto sinérgico en la inhibicion,por la mezcla en comparacion conlos compuestos individuales.
ARP000104710A 1999-09-15 2000-09-08 Composiciones farmaceuticas y/o cosmeticas AR025602A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99118285 1999-09-15

Publications (1)

Publication Number Publication Date
AR025602A1 true AR025602A1 (es) 2002-12-04

Family

ID=8239005

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000104710A AR025602A1 (es) 1999-09-15 2000-09-08 Composiciones farmaceuticas y/o cosmeticas

Country Status (15)

Country Link
US (1) US6410037B1 (es)
EP (1) EP1216021B1 (es)
AR (1) AR025602A1 (es)
AT (1) ATE289799T1 (es)
AU (1) AU7651000A (es)
CZ (1) CZ20021279A3 (es)
DE (1) DE60018438T2 (es)
DK (1) DK1216021T3 (es)
ES (1) ES2237457T3 (es)
NO (1) NO20021241D0 (es)
PL (1) PL200231B1 (es)
PT (1) PT1216021E (es)
SI (1) SI1216021T1 (es)
TR (1) TR200200666T2 (es)
WO (1) WO2001019330A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10243233A1 (de) * 2002-09-17 2004-04-15 Phenion Gmbh & Co. Kg Verwendung von Substanzen zum Schutz der Haut
WO2005060342A2 (en) * 2003-12-19 2005-07-07 Omega Bio-Pharma International Ltd. Cysteamine compounds for treating allergy
JP4301224B2 (ja) * 2005-02-16 2009-07-22 トヨタ自動車株式会社 自動車およびその制御方法
RU2472499C2 (ru) * 2007-06-08 2013-01-20 Байер Конзюмер Кер АГ Лекарственное средство, включающее комбинацию активных веществ, содержащую пантотеновую кислоту или ее производные, для лечения аллергических симптомов

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4721705A (en) * 1983-09-26 1988-01-26 Chemish Adviesbureau Drs. J.C.P. Schreuder B.V. Skin treatment compositions
GB2252905B (en) * 1991-02-11 1995-05-10 Leung Lit Hung An agent for correcting a deficiency of androgenic steroids
WO1993021899A1 (en) * 1992-05-05 1993-11-11 The Procter & Gamble Company Acne treating composition
US5425954A (en) * 1993-09-30 1995-06-20 Curafas Incorporated Topical amino acid - vitamin complex compositions for pharmaceutical and cosmetic use
DE4420625C1 (de) * 1994-06-14 1995-11-02 Beiersdorf Ag Wirkstoffkombination mit einem Gehalt an Glycerylalkylethern und kosmetische und dermatologische Zubereitungen, solche Wirkstoffkombinationen enthaltend
DE19520237A1 (de) * 1995-06-02 1996-12-05 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen, enthaltend Oligomere oder Polymere von alpha-Hydroxycarbonsäuren
DE19531893A1 (de) * 1995-08-30 1997-03-06 Bayer Ag Juckreizmildernde, kosmetische und/oder pharmazeutische Zusammensetzungen
DE19537509A1 (de) * 1995-09-27 1997-04-10 Egsto Pharm Pharmazeutische Pr Hautpflegemittel
DE19618809C1 (de) * 1996-05-10 1997-12-11 Goldwell Gmbh Kosmetisches Mittel
US5827523A (en) * 1997-04-29 1998-10-27 Holland; Dennis A. Universal topical antiseptic first aid spray
DE19739447A1 (de) * 1997-09-02 1999-03-04 Coty Bv Emulgatorfreies klares Sonnenschutzgel
DE19800982A1 (de) * 1998-01-14 1999-07-15 Foerster Karl Heinz Medizinische Salbenzubereitung

Also Published As

Publication number Publication date
SI1216021T1 (es) 2005-08-31
PL356157A1 (en) 2004-06-14
WO2001019330A1 (en) 2001-03-22
PT1216021E (pt) 2005-07-29
NO20021241L (no) 2002-03-13
ATE289799T1 (de) 2005-03-15
DK1216021T3 (da) 2005-05-23
NO20021241D0 (no) 2002-03-13
EP1216021B1 (en) 2005-03-02
DE60018438D1 (de) 2005-04-07
EP1216021A1 (en) 2002-06-26
CZ20021279A3 (cs) 2003-05-14
ES2237457T3 (es) 2005-08-01
US6410037B1 (en) 2002-06-25
PL200231B1 (pl) 2008-12-31
AU7651000A (en) 2001-04-17
TR200200666T2 (tr) 2002-06-21
DE60018438T2 (de) 2006-03-16

Similar Documents

Publication Publication Date Title
ATE323473T1 (de) Pharmazeutische zusammensetzungen enthaltend resveratrol und verwendungen davon
CN1646151B (zh) 包含原花色素、用于治疗皮炎的局部用药物组合物
WO2009086457A3 (en) 6,9-disubstituted purine derivatives and their use as cosmetics and cosmetic compositions
ES2069410T3 (es) Nuevos derivados del acido hidroxamico y n-hidroxiurea y su uso.
DOP2013000105A (es) Derivados de 2,3-dihidroimidazo[1,2-c]quinazolina sustituidos con aminoalcoholes que son de utilidad para tratar trastornos hiperproliferativos y enfermedades asociadas a la angiogénesis
WO2017182885A3 (en) Compositions for the treatment of hyperkeratosis disorders
BR112015005339A8 (pt) uso de óleo de semente de fruta milagrosa como um ingrediente ativo
MX2012007229A (es) Composicion cutanea que comprende analogo de vitamina d y mezcla de solvente y tensioactivos.
NZ594184A (en) Skin treatment
AR065317A1 (es) Uso de quitosanos, derivados de quitosanos y una sal fisiologicamente aceptable del mismo para el tratamiento de enfermedades inflamatorias ungueales
AR084197A1 (es) Composicion para uso topico para el tratamiento de trastornos de la piel
AR025602A1 (es) Composiciones farmaceuticas y/o cosmeticas
PL1867322T3 (pl) Kompozycja do zastosowania miejscowego w leczeniu łuszczycy
MX2013012038A (es) Combinacion de carotenoide, fitoestrogeno y vitamina c para la humectacion de la piel.
CA2893966C (en) Topical treatment of inflammatory skin conditions using a combination of aurin tricarboxylic, aurin quadracarboxylic and aurin hexacarboxylic acids
US20060058387A1 (en) Composition and method for treating skin conditions
DK1893237T3 (da) Farmaceutisk sammensætning, der omfatter en organopolysiloxan ela-stomer og et solubiliseret aktivt stof
BRPI0415225A (pt) composições tópicas compreendendo telmesteìna para o tratamento de distúrbios dermatológicos
AR010432A1 (es) Composiciones farmaceuticas que contienen acido ricinoleico y su uso para la terapia antiinflamatoria y analgesica
Kuśmierska et al. Our Dermatology Online
JP2016501236A5 (es)
NI201200196A (es) Agentes terapéuticos 976
TR200906775A1 (tr) Nimesulid ve kas gevşetici kombinasyonları
AR054361A1 (es) Uso de acido adamantil metoxidifenil propenoico para el tratamiento de enfermedades dermatologicas
EP3492065A1 (en) Composition for topical skin care